Enable JavaScript to visit this website.

About Premarin

Premarin may help with hot flash relief.

Hot flash monitor

PREMARIN is a treatment for moderate to severe hot flashes due to menopause that has helped generations of women.

Hot flashes are a natural part of menopause, but that doesn't mean you should have to suffer recurrent daily hot flashes.

Seven or more moderate to severe hot flashes

Seven or more moderate to severe hot flashes due to menopause a day could mean it's time to take action.

Ask your doctor about clinically proven PREMARIN today.

PREMARIN should be used at the lowest effective dose and for the shortest length of time consistent with your treatment goals and risks.

 

 

About PREMARIN® (conjugated estrogens tablets, USP) | Safety Info
Learn how PREMARIN® (conjugated estrogens tablets, USP) may help relieve moderate to severe hot flashes due to menopause. See risks and benefits of PREMARIN.

Premarin and hot flashes

Help dial down moderate to severe postmenopausal hot flashes.

Moderate to severe hot flash reduction

Premarin has been shown to help reduce the number of moderate to severe hot flashes due to menopause by over 80% at each dose studied* compared to 51% for placebo at 12 weeks.

*Number of patients studied at each dose listed next to each dosage.
0.3 mg (n=30), 0.45 mg (n=32), 0.625 mg (n=27), placebo (n=28)

You may get relief as soon as 4 weeks.

Moderate to severe hot flash reduction may start as soon as 4 weeks into treatment

Keep in mind the time it takes to experience relief can be different for different women. In a clinical trial, PREMARIN significantly reduced the number of moderate to severe hot flashes due to menopause, as compared to placebo. Some women started to experience relief as soon as 4 weeks into treatment.

At all doses studied (0.3 mg, 0.45 mg, and 0.625 mg), women taking PREMARIN experienced significantly fewer moderate to severe hot flashes versus placebo.

Talk to your doctor about whether PREMARIN may be right for you.

PREMARIN should be used at the lowest effective dose and for the shortest length of time consistent with your treatment goals and risks.

 

Hot Flash | PREMARIN® (conjugated estrogens tablets, USP) |Safety Info
Find study results for PREMARIN® (conjugated estrogens tablets, USP), for the treatment of moderate to severe hot flashes. See risks and benefits of PREMARIN.

Safety and side effects

What is the most important information you should know about PREMARIN?

Using estrogen-alone may increase your chance of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are using PREMARIN. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb). Your healthcare provider should check any unusual vaginal bleeding to find out the cause.

Do not use estrogens with or without progestins to prevent heart disease, heart attacks, strokes or dementia (decline in brain function).

Using estrogen-alone may increase your chances of getting strokes or blood clots. Using estrogens with progestins may increase your chances of getting heart attacks, strokes, breast cancer, or blood clots.

Using estrogens, with or without progestins, may increase your chance of getting dementia, based on a study of women 65 years of age or older.

You and your healthcare provider should talk regularly about whether you still need treatment.

DO NOT TAKE PREMARIN IF YOU:

  • Have unusual vaginal bleeding
  • Have or had cancer
  • Had a stroke or heart attack
  • Have or had blood clots or liver problems
  • Have a bleeding disorder
  • Are allergic to any of its ingredients
  • Think you may be pregnant

ADDITIONAL IMPORTANT INFORMATION:

  • In general, the addition of a progestin is recommended for women with a uterus to reduce the chance of getting cancer of the uterus
  • Estrogens increase the risk of gallbladder disease
  • Discontinue estrogen if loss of vision, pancreatitis, liver problems, severe increase in calcium in the blood, or a severe increase in triglycerides occur
  • If you take thyroid medication, consult your healthcare provider, as use of estrogens may change the amount needed

MOST COMMON (≥5%) SIDE EFFECTS:

  • Abdominal pain
  • Asthenia
  • Pain
  • Back pain
  • Headache
  • Flatulence
  • Nausea
  • Depression
  • Insomnia
  • Breast pain
  • Endometrial hyperplasia
  • Leucorrhea
  • Vaginal hemorrhage
  • Vaginitis

These are not all of the possible risks and side effects of PREMARIN. For more information, see Important Safety Information below and speak with your doctor.

PREMARIN should be used at the lowest effective dose and for the shortest length of time consistent with your treatment goals and risks. You and your doctor should talk regularly about treatment with PREMARIN.

Safety | PREMARIN® (conjugated estrogens tablets, USP) | Safety Info
Learn about PREMARIN® (conjugated estrogens tablets, USP) side effects and safety information. See risks and benefits of PREMARIN.
 

You are now leaving PREMARIN.com

The information provided in this website is intended only for healthcare professionals in the United States. The products discussed herein may have different product labeling in different countries.

You are now leaving the PREMARIN.com website. Links to other websites are provided as a convenience to the viewer. Pfizer accepts no responsiblity for the content of linked sites.

BACK
CONTINUE

IMPORTANT SAFETY INFORMATION AND INDICATION

Using estrogen-alone may increase your chance of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are using PREMARIN. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb). Your healthcare provider should check any unusual vaginal bleeding to find out the cause.

Do not use estrogens with or without progestins to prevent heart disease, heart attacks, strokes or dementia (decline in brain function).

Using estrogen-alone may increase your chances of getting strokes or blood clots. Using estrogens with progestins may increase your chances of getting heart attacks, strokes, breast cancer, or blood clots.

Using estrogens, with or without progestins, may increase your chance of getting dementia, based on a study of women 65 years of age or older.

Estrogens should be used at the lowest dose possible, only for as long as needed. You and your healthcare provider should talk regularly about whether you still need treatment.

PREMARIN should not be used if you have unusual vaginal bleeding, have or had cancer, had a stroke or heart attack, have or had blood clots or liver problems, have a bleeding disorder, are allergic to any of its ingredients, or think you may be pregnant. In general, the addition of a progestin is recommended for women with a uterus to reduce the chance of getting cancer of the uterus.

Estrogens increase the risk of gallbladder disease. Discontinue estrogen if loss of vision, pancreatitis, or liver problems occur. If you take thyroid medication, consult your healthcare provider, as use of estrogens may change the amount needed.

The most common (≥5%) side effects are abdominal pain, asthenia, pain, back pain, headache, flatulence, nausea, depression, insomnia, breast pain, endometrial hyperplasia, leucorrhea, vaginal hemorrhage, and vaginitis.

INDICATION

PREMARIN is used after menopause to reduce moderate to severe hot flashes.

Please see Full Prescribing Information, including BOXED WARNING and Patient Information.

Patients should always ask their doctors for medical advice about adverse events.

You are encouraged to report adverse events related to Pfizer products by calling 1-800-438-1985 (U.S. only). If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. Visit http://www.fda.gov/MedWatch or call 1-800-FDA-1088.

*Terms and Conditions

By using this PREMARIN® (conjugated estrogens tablets, USP) Co-pay Card, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:

  • Patients are not eligible to use this card if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veteran Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as “La Reforma de Salud”).
  • Patient must have private insurance. Offer is not valid for cash paying patients. The value of this co-pay card is limited to $55 per use or the amount of your co-pay, whichever is less.
  • This co-pay card is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plan or other private health or pharmacy benefit programs.
  • You must deduct the value of this co-pay card from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf.
  • Eligible patients will pay a minimum of $15 with a savings of up to $55 per prescription fill. Limit 12 offers per calendar year.
    • If your out-of-pocket cost is $70 or less, you will pay $15 and save up to $55.
    • If your out-of-pocket cost is more than $70, you will save up to $55 with this co-pay card and you must cover the remaining expenses.
  • Maximum savings of $660 per calendar year. After you have reached the limit of $660, you will pay monthly out-of-pocket costs.
  • You are responsible for reporting use of the co-pay card to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the co-pay card, as may be required. You should not use the co-pay card if your insurer or health plan prohibits use of manufacturer co-pay cards.
  • You must be 18 years of age or older to redeem the co-pay card.
  • This co-pay card is not valid where prohibited by law.
  • Co-pay card cannot be combined with any other savings, free trial or similar offer for the specified prescription.
  • Co-pay card will be accepted only at participating pharmacies.
  • If your pharmacy does not participate, you may be able to submit a request for a rebate in connection with this offer.
  • This co-pay card is not health insurance.
  • Offer good only in the U.S. and Puerto Rico.
  • Co-pay card is limited to 1 per person during this offering period and is not transferable.
  • A co-pay card may not be redeemed more than once per month per patient.
  • No other purchase is necessary.
  • Data related to your redemption of the co-pay card may be collected, analyzed, and shared with Pfizer, for market research and other purposes related to assessing Pfizer’s programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other co-pay card redemptions and will not identify you.
  • Pfizer reserves the right to rescind, revoke or amend this offer without notice.
  • Offer expires 12/31/2020.

For reimbursement when using a nonparticipating pharmacy/mail order:

Pay for PREMARIN prescription and mail copy of original pharmacy receipt (cash register receipt NOT valid) with product name, date, and amount circled to: PREMARIN Co-pay Card, P.O. Box 4939, Warren, NJ 07059-6600. Be sure to include a copy of the front of your Co-pay Card, your name, and mailing address.

For help with the PREMARIN Co-pay Card, call 1-866-410-3700.

 

IMPORTANT SAFETY INFORMATION AND INDICATION

Using estrogen-alone may increase your chance of getting cancer of the uterus (womb). Report any unusual vaginal bleeding right away while you are using PREMARIN. Vaginal bleeding after menopause may be a warning sign of cancer of the uterus (womb). Your healthcare provider should check any unusual vaginal bleeding to find out the cause.

Do not use estrogens with or without progestins to prevent heart disease, heart attacks, strokes or dementia (decline in brain function).

Using estrogen-alone may increase your chances of getting strokes or blood clots. Using estrogens with progestins may increase your chances of getting heart attacks, strokes, breast cancer, or blood clots.

Using estrogens, with or without progestins, may increase your chance of getting dementia, based on a study of women 65 years of age or older.

Estrogens should be used at the lowest dose possible, only for as long as needed. You and your healthcare provider should talk regularly about whether you still need treatment.

PREMARIN should not be used if you have unusual vaginal bleeding, have or had cancer, had a stroke or heart attack, have or had blood clots or liver problems, have a bleeding disorder, are allergic to any of its ingredients, or think you may be pregnant. In general, the addition of a progestin is recommended for women with a uterus to reduce the chance of getting cancer of the uterus.

Estrogens increase the risk of gallbladder disease. Discontinue estrogen if loss of vision, pancreatitis, or liver problems occur. If you take thyroid medication, consult your healthcare provider, as use of estrogens may change the amount needed.

The most common (≥5%) side effects are abdominal pain, asthenia, pain, back pain, headache, flatulence, nausea, depression, insomnia, breast pain, endometrial hyperplasia, leucorrhea, vaginal hemorrhage, and vaginitis.

INDICATION

PREMARIN is used after menopause to reduce moderate to severe hot flashes.

Please see Full Prescribing Information, including BOXED WARNING and Patient Information.

Patients should always ask their doctors for medical advice about adverse events.

You are encouraged to report adverse events related to Pfizer products by calling 1-800-438-1985 (U.S. only). If you prefer, you may contact the U.S. Food and Drug Administration (FDA) directly. Visit http://www.fda.gov/MedWatch or call 1-800-FDA-1088.

*Terms and Conditions

By using this PREMARIN® (conjugated estrogens tablets, USP) Co-pay Card, you acknowledge that you currently meet the eligibility criteria and will comply with the terms and conditions described below:

  • Patients are not eligible to use this card if they are enrolled in a state or federally funded insurance program, including but not limited to Medicare, Medicaid, TRICARE, Veteran Affairs health care, a state prescription drug assistance program, or the Government Health Insurance Plan available in Puerto Rico (formerly known as “La Reforma de Salud”).
  • Patient must have private insurance. Offer is not valid for cash paying patients. The value of this co-pay card is limited to $55 per use or the amount of your co-pay, whichever is less.
  • This co-pay card is not valid when the entire cost of your prescription drug is eligible to be reimbursed by your private insurance plan or other private health or pharmacy benefit programs.
  • You must deduct the value of this co-pay card from any reimbursement request submitted to your private insurance plan, either directly by you or on your behalf.
  • Eligible patients will pay a minimum of $15 with a savings of up to $55 per prescription fill. Limit 12 offers per calendar year.
    • If your out-of-pocket cost is $70 or less, you will pay $15 and save up to $55.
    • If your out-of-pocket cost is more than $70, you will save up to $55 with this co-pay card and you must cover the remaining expenses.
  • Maximum savings of $660 per calendar year. After you have reached the limit of $660, you will pay monthly out-of-pocket costs.
  • You are responsible for reporting use of the co-pay card to any private insurer, health plan, or other third party who pays for or reimburses any part of the prescription filled using the co-pay card, as may be required. You should not use the co-pay card if your insurer or health plan prohibits use of manufacturer co-pay cards.
  • You must be 18 years of age or older to redeem the co-pay card.
  • This co-pay card is not valid where prohibited by law.
  • Co-pay card cannot be combined with any other savings, free trial or similar offer for the specified prescription.
  • Co-pay card will be accepted only at participating pharmacies.
  • If your pharmacy does not participate, you may be able to submit a request for a rebate in connection with this offer.
  • This co-pay card is not health insurance.
  • Offer good only in the U.S. and Puerto Rico.
  • Co-pay card is limited to 1 per person during this offering period and is not transferable.
  • A co-pay card may not be redeemed more than once per month per patient.
  • No other purchase is necessary.
  • Data related to your redemption of the co-pay card may be collected, analyzed, and shared with Pfizer, for market research and other purposes related to assessing Pfizer’s programs. Data shared with Pfizer will be aggregated and de-identified; it will be combined with data related to other co-pay card redemptions and will not identify you.
  • Pfizer reserves the right to rescind, revoke or amend this offer without notice.
  • Offer expires 12/31/2020.

For reimbursement when using a nonparticipating pharmacy/mail order:

Pay for PREMARIN prescription and mail copy of original pharmacy receipt (cash register receipt NOT valid) with product name, date, and amount circled to: PREMARIN Co-pay Card, P.O. Box 4939, Warren, NJ 07059-6600. Be sure to include a copy of the front of your Co-pay Card, your name, and mailing address.

For help with the PREMARIN Co-pay Card, call 1-866-410-3700.